Literature DB >> 19129390

Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration.

Qi Chen1, Charles A Peto, G Diane Shelton, Andrew Mizisin, Paul E Sawchenko, David Schubert.   

Abstract

Axonal dysfunction is the major phenotypic change in many neurodegenerative diseases, but the processes underlying this impairment are not clear. Modifier of cell adhesion (MOCA) is a presenilin binding protein that functions as a guanine nucleotide exchange factor for Rac1. The loss of MOCA in mice leads to axonal degeneration and causes sensorimotor impairments by decreasing cofilin phosphorylation and altering its upstream signaling partners LIM kinase and p21-activated kinase, an enzyme directly downstream of Rac1. The dystrophic axons found in MOCA-deficient mice are associated with abnormal aggregates of neurofilament protein, the disorganization of the axonal cytoskeleton, and the accumulation of autophagic vacuoles and polyubiquitinated proteins. Furthermore, MOCA deficiency causes an alteration in the actin cytoskeleton and the formation of cofilin-containing rod-like structures. The dystrophic axons show functional abnormalities, including impaired axonal transport. These findings demonstrate that MOCA is required for maintaining the functional integrity of axons and define a model for the steps leading to axonal degeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129390      PMCID: PMC2669744          DOI: 10.1523/JNEUROSCI.3985-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

Review 1.  Axon degeneration mechanisms: commonality amid diversity.

Authors:  Michael Coleman
Journal:  Nat Rev Neurosci       Date:  2005-11       Impact factor: 34.870

Review 2.  Synaptic remodeling during aging and in Alzheimer's disease.

Authors:  Eliezer Masliah; Leslie Crews; Lawrence Hansen
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

Review 3.  Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking.

Authors:  Anne J Ridley
Journal:  Trends Cell Biol       Date:  2006-09-01       Impact factor: 20.808

4.  Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.

Authors:  Taichi Hara; Kenji Nakamura; Makoto Matsui; Akitsugu Yamamoto; Yohko Nakahara; Rika Suzuki-Migishima; Minesuke Yokoyama; Kenji Mishima; Ichiro Saito; Hideyuki Okano; Noboru Mizushima
Journal:  Nature       Date:  2006-04-19       Impact factor: 49.962

Review 5.  Axonal transport and neurodegenerative disease.

Authors:  Erica Chevalier-Larsen; Erika L F Holzbaur
Journal:  Biochim Biophys Acta       Date:  2006-04-19

6.  Tryptamine induces cell death with ultrastructural features of autophagy in neurons and glia: Possible relevance for neurodegenerative disorders.

Authors:  Federico Herrera; Vanesa Martin; Pilar Carrera; Guillermo García-Santos; Jezabel Rodriguez-Blanco; Carmen Rodriguez; Isaac Antolín
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2006-09

Review 7.  Autophagy in neurodegenerative disease: friend, foe or turncoat?

Authors:  Ralph A Nixon
Journal:  Trends Neurosci       Date:  2006-07-20       Impact factor: 13.837

Review 8.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics.

Authors:  Piera Pasinelli; Robert H Brown
Journal:  Nat Rev Neurosci       Date:  2006-09       Impact factor: 34.870

Review 9.  The roles of intracellular protein-degradation pathways in neurodegeneration.

Authors:  David C Rubinsztein
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

Review 10.  The genetics of axonal transport and axonal transport disorders.

Authors:  Jason E Duncan; Lawrence S B Goldstein
Journal:  PLoS Genet       Date:  2006-09-29       Impact factor: 5.917

View more
  32 in total

1.  Dock3 Participate in Epileptogenesis Through rac1 Pathway in Animal Models.

Authors:  Jie Li; Xiujuan Mi; Ling Chen; Guohui Jiang; Na Wang; Yujiao Zhang; Wanni Deng; Zhihua Wang; Guojun Chen; Xuefeng Wang
Journal:  Mol Neurobiol       Date:  2015-08-30       Impact factor: 5.590

2.  The atypical guanine nucleotide exchange factor Dock4 regulates neurite differentiation through modulation of Rac1 GTPase and actin dynamics.

Authors:  Yangui Xiao; Yinghui Peng; Jun Wan; Genyun Tang; Yuewen Chen; Jing Tang; Wen-Cai Ye; Nancy Y Ip; Lei Shi
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

3.  Fine-Tuning of the Actin Cytoskeleton and Cell Adhesion During Drosophila Development by the Unconventional Guanine Nucleotide Exchange Factors Myoblast City and Sponge.

Authors:  Bridget Biersmith; Zong-Heng Wang; Erika R Geisbrecht
Journal:  Genetics       Date:  2015-04-23       Impact factor: 4.562

4.  Variants in DOCK3 cause developmental delay and hypotonia.

Authors:  Kimberly Wiltrout; Alejandro Ferrer; Ingrid van de Laar; Kazuhiko Namekata; Takayuki Harada; Eric W Klee; Michael T Zimmerman; Margot A Cousin; Jennifer L Kempainen; Dusica Babovic-Vuksanovic; Marjon A van Slegtenhorst; Coranne D Aarts-Tesselaar; Rhonda E Schnur; Marisa Andrews; Marwan Shinawi
Journal:  Eur J Hum Genet       Date:  2019-04-11       Impact factor: 4.246

5.  Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function.

Authors:  Jiandong Sun; Yan Liu; Stephanie Moreno; Michel Baudry; Xiaoning Bi
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

6.  Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex.

Authors:  Kazuhiko Namekata; Chikako Harada; Choji Taya; Xiaoli Guo; Hideo Kimura; Luis F Parada; Takayuki Harada
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

7.  Regulation of chandelier cell cartridge and bouton development via DOCK7-mediated ErbB4 activation.

Authors:  Yilin Tai; Justyna A Janas; Chia-Lin Wang; Linda Van Aelst
Journal:  Cell Rep       Date:  2014-01-16       Impact factor: 9.423

8.  DOCK3-related neurodevelopmental syndrome: Biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia.

Authors:  Aiko Iwata-Otsubo; Alyssa L Ritter; Brooke Weckselbatt; Nicole R Ryan; David Burgess; Laura K Conlin; Kosuke Izumi
Journal:  Am J Med Genet A       Date:  2017-11-12       Impact factor: 2.802

9.  Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.

Authors:  Shilpa Prabhakar; Mehran Taherian; Davide Gianni; Thomas J Conlon; Giulia Fulci; Jillian Brockmann; Anat Stemmer-Rachamimov; Miguel Sena-Esteves; Xandra O Breakefield; Gary J Brenner
Journal:  Hum Gene Ther       Date:  2013-01-30       Impact factor: 5.695

10.  MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.

Authors:  Matthew S Alexander; Juan Carlos Casar; Norio Motohashi; Natássia M Vieira; Iris Eisenberg; Jamie L Marshall; Molly J Gasperini; Angela Lek; Jennifer A Myers; Elicia A Estrella; Peter B Kang; Frederic Shapiro; Fedik Rahimov; Genri Kawahara; Jeffrey J Widrick; Louis M Kunkel
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.